EP4712795A2 - Ernährungszusammensetzung und verfahren zur förderung des schlafs und/oder zur behandlung und/oder prävention von schlafstörungen - Google Patents

Ernährungszusammensetzung und verfahren zur förderung des schlafs und/oder zur behandlung und/oder prävention von schlafstörungen

Info

Publication number
EP4712795A2
EP4712795A2 EP24724265.4A EP24724265A EP4712795A2 EP 4712795 A2 EP4712795 A2 EP 4712795A2 EP 24724265 A EP24724265 A EP 24724265A EP 4712795 A2 EP4712795 A2 EP 4712795A2
Authority
EP
European Patent Office
Prior art keywords
sleep
nutritional composition
combination
composition
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP24724265.4A
Other languages
English (en)
French (fr)
Inventor
Laurent Ferrier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe des Produits Nestle SA
Nestle SA
Original Assignee
Societe des Produits Nestle SA
Nestle SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe des Produits Nestle SA, Nestle SA filed Critical Societe des Produits Nestle SA
Publication of EP4712795A2 publication Critical patent/EP4712795A2/de
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nutrition Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pediatric Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
EP24724265.4A 2023-05-16 2024-05-07 Ernährungszusammensetzung und verfahren zur förderung des schlafs und/oder zur behandlung und/oder prävention von schlafstörungen Pending EP4712795A2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP23173707 2023-05-16
PCT/EP2024/062523 WO2024235730A2 (en) 2023-05-16 2024-05-07 Nutritional composition

Publications (1)

Publication Number Publication Date
EP4712795A2 true EP4712795A2 (de) 2026-03-25

Family

ID=86386966

Family Applications (1)

Application Number Title Priority Date Filing Date
EP24724265.4A Pending EP4712795A2 (de) 2023-05-16 2024-05-07 Ernährungszusammensetzung und verfahren zur förderung des schlafs und/oder zur behandlung und/oder prävention von schlafstörungen

Country Status (7)

Country Link
EP (1) EP4712795A2 (de)
CN (1) CN121263075A (de)
AU (1) AU2024270754A1 (de)
CL (1) CL2025003559A1 (de)
CO (1) CO2025016971A2 (de)
MX (1) MX2025013704A (de)
WO (1) WO2024235730A2 (de)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5180674A (en) 1990-04-16 1993-01-19 The Trustees Of The University Of Pennsylvania Saccharide compositions, methods and apparatus for their synthesis
US5545553A (en) 1994-09-26 1996-08-13 The Rockefeller University Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them
US11357785B2 (en) * 2017-12-22 2022-06-14 Societe Des Produits Nestle S.A. Compositions for use in the reduction of nociception in infants and young children
EP3897205A1 (de) * 2018-12-21 2021-10-27 Société des Produits Nestlé S.A. Ernährungszusammensetzung mit 6'sl und lnt in kombination zur verbesserung der magen-darm-barrierefunktion
BR112022008956A2 (pt) * 2019-12-06 2022-08-02 Nestle Sa Composições para uso na redução de dor e/ou percepção de dor em bebês e crianças pequenas
CN114786501A (zh) * 2019-12-11 2022-07-22 雀巢产品有限公司 用于减少婴儿和幼儿的伤害感觉和/或其他健康益处的组合物
JP2023553548A (ja) * 2020-12-04 2023-12-22 グリコム・アクティーゼルスカブ 睡眠パターンの成熟又は改善の支援に使用するためのヒト母乳オリゴ糖
WO2022118270A1 (en) * 2020-12-04 2022-06-09 Glycom A/S Human milk oligosaccharides for use in supporting night sleep duration

Also Published As

Publication number Publication date
CL2025003559A1 (es) 2026-01-16
WO2024235730A2 (en) 2024-11-21
WO2024235730A3 (en) 2024-12-26
CN121263075A (zh) 2026-01-02
MX2025013704A (es) 2026-02-03
AU2024270754A1 (en) 2025-11-27
CO2025016971A2 (es) 2025-12-19

Similar Documents

Publication Publication Date Title
Hernell et al. Clinical benefits of milk fat globule membranes for infants and children
TWI332399B (en) Nutritional composition for controlling blood sugar level
TWI722992B (zh) 腦功能改善劑、及認知功能障礙的預防或治療劑
JP2015503913A (ja) 認知機能の発達のためのラクトバチルス・ロイテリdsm17938
US12533369B2 (en) Mixture of HMOS for improving the microbiota of pregnant women
JP2015508396A (ja) 腸管神経系の発達のためのラクトバチルス・ロイテリdsm17938
HK1209000A1 (en) Maternal sialic acid supplementation
US20250360151A1 (en) Nutritional composition comprising gos and hmos
US20240000122A1 (en) Compositions comprising human milk oligosaccharides for use in a subject to support night sleep duration
CN115209745A (zh) 用于在个体中使用以支持语言发育的包含人乳低聚糖的组合物
US20240000818A1 (en) Compositions comprising human milk oligosaccharides for use in a subject to support maturation of sleeping patterns
AU2024270754A1 (en) Nutritional composition and method for promoting sleep and/or for treating and/or preventing sleep disorders
US20240024343A1 (en) Human milk oligosaccharides for use in supporting maturation or improvement of sleeping patterns
RU2851195C1 (ru) Композиции, содержащие олигосахариды грудного молока, предназначенные для применения у субъектов для поддержки развития языковых навыков
RU2819351C2 (ru) Композиция, содержащая олигосахариды грудного молока, для применения в улучшении, усилении, стимулировании или модулировании серотонинергической функции в центральной нервной системе
WO2024240923A1 (en) Prebiotics for treating and/or preventing vitamin k2 deficiency
WO2025196272A1 (en) Combination of mixtures of hmos with mfgm and their use
WO2024240925A1 (en) Combination of vitamins, 2'-fucosyllactose and a probiotic for enhancing bone growth and/or bone strength
US20220195332A1 (en) Dietary butyrate and its uses
WO2024240927A1 (en) Combination for enhancing bone growth and/or bone strength
DK202430499A1 (en) Combination of mixtures of hmos with mfgm and their use
EP4701441A1 (de) Zusammensetzung zur verwendung in einer person
WO2025045657A1 (en) Compositions comprising human milk oligosaccharides for use in a subject to support brain development and/or social-emotional development
WO2025196273A1 (en) Combination of mixtures of hmos with mfgm and their use
HK1230931A1 (en) Brain function improving agent, and prophylactic or therapeutic agent for cognitive dysfunction

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20251216

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR